Weekly Market Recap (December 15–19, 2025)
Choppy but constructive: Nasdaq outperformed while Dow slipped. Basic Materials and Energy led; defensives lagged. IPO risk appetite returned.
Index Performance (Weekly)
| Index | Weekly Change |
|---|---|
| S&P 500 | +0.26% |
| Nasdaq | +1.09% |
| Dow Jones | −0.58% |
Sector Snapshot (1-Week)
AI Picks Performance (Week)
| Stock | Weekly Return | Comment |
|---|---|---|
| Applied Materials (AMAT) | −1.86% | Semi-cap consolidation despite Tech strength. |
| Alphabet (GOOGL) | −0.34% | Muted week vs. Comm Services gains. |
| Eli Lilly (LLY) | +0.87% | GLP-1 momentum supported Healthcare. |
The Score — Stocks That Defined the Week
- Medline (MDLN): Biggest U.S. IPO of 2025 raised >$6B; shares +41% on debut; valuation >$50B.
- Micron Technology (MU): AI memory shortages boosted FQ1 revenue; raised outlook; shares +10% Thu.
- Tesla (TSLA): California DMV ordered changes to “Autopilot/FSD” marketing; potential license suspension timeline; shares −4.6% Wed.
- Warner Bros. Discovery (WBD): Rejected Paramount Skydance’s hostile bid; proceeding with $72B Netflix deal; WBD −2.4% Wed, PSKY −5.4%.
- Trump Media & Technology: Agreed all-stock merger with fusion firm TAE to target AI power demand; shares +42% Thu.
- Lululemon (LULU): Elliott disclosed >$1B stake; pushes CEO pick Jane Nielsen; shares +3.5% Thu.
Outlook
- Leadership: Materials/Energy bid suggests cyclical updraft into year-end while defensives lag.
- AI Supply Chain: Memory pricing tightness favors MU; watch semi-cap orders for early-2026 color.
- Deals/IPO window: Medline pop and ongoing media M&A keep dispersion high into the holidays.
Key Takeaway
Cyclicals carried the tape—Materials, Energy and Tech—while defensives faded. Risk appetite re-appeared via a blockbuster IPO, upbeat MU guidance, and headline-heavy media/alt-energy deals.
Week ended December 19, 2025. Data based on your inputs and summaries provided.
